Zhao et al. (2015) demonstrated that 2-MCA reduced brain edema and brain injuries through reduction of expression of receptors and factors such as toll-like receptor 4 (TLR4) and NF-κB as well as reduction of inflammatory mediators such as TNF- α and IL-1β (43). The gene discussed is IL1B; the disease is brain injury.